The role of Arimidex 1 mg and Aromasin 25 mg in postmenopausal women undergoing cancer treatment
Aromatase inhibitors, including Arimidex (anastrozole) and Aromasin (exemestane), are prescribed to postmenopausal women with hormone receptor-positive breast cancer.